Bond Screener
Eli Lilly
LEI FRDRIPF3EKNDJ2CQJL29, SWIFT LLYCUS33XXX
Organization name
Eli Lilly & Company
Country name
USA
Country of registration
USA
Industry
Pharmaceutical Preparation and Biotechnology
Credit Ratings
in foreign currency
Public debt
51,152 mln USD
New to Cbonds? · Take a 90-second tour of the platform.
Discover what you can do with Cbonds
Everything you need for fixed income research and monitoring.
- 00:23 Coverage
- 00:40 Bond screener
- 00:54 Parameters
- 01:10 Watchlist, Mobile app
- 01:15 Excel Add-in
Trading Schedule Issuer map
Quotes
/
/
/
pcs.
pcs.
pcs.
- «
- 1
- ...
- {{ quotes.page - 2 }}
- {{ quotes.page - 1 }}
- {{ quotes.page }}
- {{ quotes.page + 1 }}
- {{ quotes.page + 2 }}
- ...
- {{ quotesLastPage }}
- »
Quotes provided by information providers are indicative in nature
Profile
|
Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products for humans and animals. The Company products are sold in countries around the world. Eli Lilly products include neuroscience, endocrine, anti-infectives, cardiovascular agents, oncology, and animal health products.
|
General information
-
Organization nameEli Lilly & Company
-
Organization statusOperating organization
-
AddressLilly Corporation Centre, Indianapolis, USA, 46285
-
Site
-
IR Site
News
-
Eli Lilly Just Announced Something Big. Here's What It Means for Investors.04/10/2026
-
Lilly Just Reported More Than Half of Patients on Its New Weight Loss Drug Lost 20% of Their Body Weight -- and a Third Lost 25%. Here's How the News Could Shake Up the Obesity Drug Market.30/09/2026
-
2 Outstanding Dividend Stocks to Buy and Hold for a Decade30/09/2026
-
Opinion: Eli Lilly Stock Is a No-Brainer Pick to Buy on the Dip30/09/2026
-
Eli Lilly Might Be the Next Stock I Buy30/09/2026
IFRS/US GAAP reports
| 2026 | |
| 2025 | |
| 2024 | |
| 2023 | |
| 2022 | |
| 2021 | |
| 2020 | |
| 2019 | |
| 2018 | |
| 2017 | |
| 2016 | |
| 2015 | |
| 2014 | |
Show more
Hide
Authorization required
You need to request access
Stocks
General information
-
Organization nameEli Lilly & Company
-
Organization statusOperating organization
-
AddressLilly Corporation Centre, Indianapolis, USA, 46285
-
Site
-
IR Site
Codes
-
LEIFRDRIPF3EKNDJ2CQJL29
-
SWIFTLLYCUS33XXX
-
SIC2834 PHARMACEUTICAL PREPARATIONS
-
ICB4,500 Health Care
-
NACE*** ***
-
NAICS*** ***
-
CIK0000059478
-
EIN35-0470950
